These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 31706844)

  • 1. Methylation of adenosine at the N
    Nakano M; Ondo K; Takemoto S; Fukami T; Nakajima M
    Biochem Pharmacol; 2020 Jan; 171():113697. PubMed ID: 31706844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m
    Takemoto S; Nakano M; Fukami T; Nakajima M
    Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine N
    Isono M; Nakano M; Fukami T; Nakajima M
    Biochem Pharmacol; 2022 Nov; 205():115247. PubMed ID: 36113565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N
    Ondo K; Isono M; Nakano M; Hashiba S; Fukami T; Nakajima M
    Biochem Pharmacol; 2021 Jul; 189():114402. PubMed ID: 33387482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3/METTL14 Transactivation and m
    Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N (6)-Methyladenosine (m(6)A) Methylation in mRNA with A Dynamic and Reversible Epigenetic Modification.
    Wu R; Jiang D; Wang Y; Wang X
    Mol Biotechnol; 2016 Jul; 58(7):450-9. PubMed ID: 27179969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
    Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in aldo-keto reductase 1D1 (AKR1D1) affects the expression and activity of multiple cytochrome P450s.
    Chaudhry AS; Thirumaran RK; Yasuda K; Yang X; Fan Y; Strom SC; Schuetz EG
    Drug Metab Dispos; 2013 Aug; 41(8):1538-47. PubMed ID: 23704699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    He PC; He C
    EMBO J; 2021 Feb; 40(3):e105977. PubMed ID: 33470439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of N
    Lu Z; Ma Y; Li Q; Liu E; Jin M; Zhang L; Wei C
    Cell Stress Chaperones; 2019 Mar; 24(2):333-342. PubMed ID: 30701478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms.
    Nozaki K; Nakano M; Iwakami C; Fukami T; Nakajima M
    Drug Metab Dispos; 2019 Jun; 47(6):639-647. PubMed ID: 30988053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.
    Chen Y; Zeng L; Wang Y; Tolleson WH; Knox B; Chen S; Ren Z; Guo L; Mei N; Qian F; Huang K; Liu D; Tong W; Yu D; Ning B
    Biochem Pharmacol; 2017 Dec; 145():178-191. PubMed ID: 28822783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of cytochrome P450 2C8 by 3-methylcholanthrene in human hepatocellular carcinoma cell lines.
    Utgikar R; Riddick DS
    Can J Physiol Pharmacol; 2017 Jun; 95(6):768-771. PubMed ID: 28384415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function.
    Niu Y; Zhao X; Wu YS; Li MM; Wang XJ; Yang YG
    Genomics Proteomics Bioinformatics; 2013 Feb; 11(1):8-17. PubMed ID: 23453015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
    Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic m(6)A mRNA methylation directs translational control of heat shock response.
    Zhou J; Wan J; Gao X; Zhang X; Jaffrey SR; Qian SB
    Nature; 2015 Oct; 526(7574):591-4. PubMed ID: 26458103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and evolution of RNA N6-methyladenosine modification.
    Zhu ZM; Huo FC; Pei DS
    Int J Biol Sci; 2020; 16(11):1929-1940. PubMed ID: 32398960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.